Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3

被引:57
作者
Nielsen, M
Nissen, MH
Gerwien, J
Zocca, MB
Rasmussen, HM
Nakajima, K
Röpke, C
Geisler, C
Kaltoft, K
Odum, N
机构
[1] Univ Copenhagen, Inst Med Microbiol & Immunol, DK-2200 Copenhagen N, Denmark
[2] Univ Copenhagen, Inst Med Anat, Sect A, DK-2200 Copenhagen, Denmark
[3] Osaka City Med Sch, Dept Immunol, Osaka, Japan
[4] Univ Aarhus, Inst Human Genet, DK-8000 Aarhus C, Denmark
关键词
D O I
10.1182/blood.V99.3.973
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mycosis fungoides is a low-grade cutanous T-cell lymphoma (CTCL) of unknown etiology. In advanced stages of CTCL, a shift in cytokine profile from T(H)1 to T(H)2 is observed, which coincides with eosinophilia, high levels of immunoglobulin E, and increased susceptibility to bacterial infections. It is, however, unknown why T(H)2 cytokines predominate in advanced CTCL, and the cellular source of these cytokines also remains to be identified. In several leukemias and lymphomas, constitutively activated signal transducer and activator of transcription (Stat) signaling pathways have been detected. In a previous study, constitutive activation of Stat3 was found in tumor cells isolated from affected skin and blood from CTCL patients. Here, it is shown that CTCL tumor cell lines, but not nonmalignant cell lines, spontaneously produce interleukin-5 (IL-5), IL-6, and IL-13. Transfection of tumor cells with dominant-negative Stat3 almost completely blocks IL-5 production and strongly inhibits IL-13 production, whereas IL-6 production is unaffected. Thus, the data show that malignant CTCL cells themselves might contribute to the change in cytokine pattern accompanying progression of CTCL. In conclusion, constitutively activated Stat3 is found to mediate a spontaneous IL-5 production and regulate IL-13 production in CTCL cell lines, pointing toward a new role of Stat3 in malignant transformation. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:973 / 977
页数:5
相关论文
共 30 条
[1]   Interferon-alpha induces transient suppressors of cytokine signalling expression in human T cells [J].
Brender, C ;
Nielsen, M ;
Röpke, C ;
Nissen, MH ;
Svejgaard, A ;
Billestrup, N ;
Geisler, C ;
Odum, N .
EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, 2001, 18 (02) :80-85
[2]   STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma [J].
Brender, C ;
Nielsen, M ;
Kaltoft, K ;
Mikkelsen, G ;
Zhang, Q ;
Wasik, M ;
Billestrup, N ;
Odum, N .
BLOOD, 2001, 97 (04) :1056-1062
[3]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[4]   THE ASSOCIATION OF EOSINOPHILIA WITH LYMPHOBLASTIC-LEUKEMIA OR LYMPHOMA - A STUDY OF 7 PATIENTS [J].
CATOVSKY, D ;
BERNASCONI, C ;
VERDONCK, PJ ;
POSTMA, A ;
HOWS, J ;
VANDERDOESVANDENBERG, A ;
REES, JKH ;
CASTELLI, G ;
MORRA, E ;
GALTON, DAG .
BRITISH JOURNAL OF HAEMATOLOGY, 1980, 45 (04) :523-&
[5]   CONCURRENT EOSINOPHILIC FASCIITIS AND CUTANEOUS T-CELL LYMPHOMA - EOSINOPHILIC FASCIITIS AS A PARANEOPLASTIC SYNDROME OF T-CELL MALIGNANT NEOPLASMS [J].
CHAN, LS ;
HANSON, CA ;
COOPER, KD .
ARCHIVES OF DERMATOLOGY, 1991, 127 (06) :862-865
[6]   Mycosis fungoides and Sezary syndrome [J].
Diamandidou, E ;
Cohen, PR ;
Kurzrock, R .
BLOOD, 1996, 88 (07) :2385-2409
[7]   Eosinophilia in Hodgkin's disease: A role for interleukin 5 [J].
DiBiagio, E ;
SanchezBorges, M ;
Desenne, JJ ;
SuarezChacon, R ;
Somoza, R ;
Acquatella, G .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 110 (03) :244-251
[8]   Constitutive STAT3-activation in Sezary syndrome:: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells [J].
Eriksen, KW ;
Kaltoft, K ;
Mikkelsen, G ;
Nielsen, M ;
Zhang, Q ;
Geisler, C ;
Nissen, MH ;
Röpke, C ;
Wasik, MA ;
Odum, N .
LEUKEMIA, 2001, 15 (05) :787-793
[9]  
ERIKSEN KW, 2001, EXP CLIN IMMUNOGENET
[10]   T-cell clones from early-stage cutaneous T-cell lymphoma show no polarized Th-1 or Th-2 cytokine profile [J].
Harwix, S ;
Zachmann, K ;
Neumann, C .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2000, 292 (01) :1-8